Loading...

Ultragenyx Pharmaceutical Inc.

RARENASDAQ
Healthcare
Biotechnology
$28.44
$1.12(4.10%)

Ultragenyx Pharmaceutical Inc. (RARE) Financial Performance & Income Statement Overview

Review Ultragenyx Pharmaceutical Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
29.01%
29.01%
Operating Income Growth
5.84%
5.84%
Net Income Growth
6.17%
6.17%
Operating Cash Flow Growth
12.77%
12.77%
Operating Margin
-86.94%
86.94%
Gross Margin
83.63%
83.63%
Net Profit Margin
-93.04%
93.04%
ROE
-186.49%
186.49%
ROIC
-50.34%
50.34%

Ultragenyx Pharmaceutical Inc. (RARE) Income Statement & Financial Overview

Review Ultragenyx Pharmaceutical Inc.'s (RARE) income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$139.29M$164.88M$139.49M$147.03M
Cost of Revenue$28.66M$16.89M$21.02M$30.14M
Gross Profit$110.63M$147.98M$118.47M$116.88M
Gross Profit Ratio$0.79$0.90$0.85$0.79
R&D Expenses$165.77M$187.77M$170.11M$152.64M
SG&A Expenses$87.80M$82.50M$80.35M$80.60M
Operating Expenses$253.57M$270.26M$250.46M$233.25M
Total Costs & Expenses$282.23M$287.15M$271.48M$263.39M
Interest Income$6.83M$9.55M$10.73M$7.40M
Interest Expense$14.34M$15.52M$15.71M$15.96M
Depreciation & Amortization$8.99M$9.08M$8.76M$8.86M
EBITDA-$126.44M-$108.80M-$108.74M-$105.92M
EBITDA Ratio-$0.91-$0.66-$0.78-$0.72
Operating Income-$142.94M-$122.28M-$131.99M-$116.36M
Operating Income Ratio-$1.03-$0.74-$0.95-$0.79
Other Income/Expenses (Net)-$6.83M-$11.13M-$1.23M-$14.38M
Income Before Tax-$149.77M-$133.40M-$133.21M-$130.74M
Income Before Tax Ratio-$1.08-$0.81-$0.95-$0.89
Income Tax Expense$1.31M-$19000.00$303000.00$858000.00
Net Income-$151.08M-$133.38M-$133.52M-$131.60M
Net Income Ratio-$1.08-$0.81-$0.96-$0.90
EPS-$1.57-$1.39-$1.40-$1.52
Diluted EPS-$1.57-$1.39-$1.40-$1.52
Weighted Avg Shares Outstanding$96.29M$95.68M$95.49M$86.58M
Weighted Avg Shares Outstanding (Diluted)$96.29M$95.68M$95.49M$86.58M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;